+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical Excipients Market Research Report by Product (Carbohydrates, Polyols, and Solubilizers & Surfactants/Emulsifiers), Function, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5337416
  • Report
  • April 2022
  • Region: Global
  • 203 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • ABITEC Corporation
  • Clariant AG
  • DFE Pharma GmbH & Co. KG
  • IMCD N.V.
  • Meggle Group GmbH
  • Roquette Freres SA
The Global Biopharmaceutical Excipients Market size was estimated at USD 1,725.43 million in 2020, USD 1,894.21 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.34% to reach USD 3,437.75 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biopharmaceutical Excipients to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Specialty Excipients. The Carbohydrates is further studied across Dextrose, Starch, and Sucrose. The Polyols is further studied across Mannitol and Sorbitol. The Solubilizers & Surfactants/Emulsifiers is further studied across Esters and Triglycerides.
  • Based on Function, the market was studied across Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers, and Preservatives.
  • Based on Application, the market was studied across Advanced Delivery System, Oral, Parenteral, and Topical.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Arizona, California, Colorado, Florida, Illinois, Massachusetts, Michigan, Nevada, Ohio, Oregon, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceutical Excipients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceutical Excipients Market, including ABITEC Corporation, Ashland Global Holdings Inc., BASF SE, Clariant AG, Colorcon, Inc., DFE Pharma GmbH & Co. KG, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Söhne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Pharmonix Biologicals Pvt. Ltd., Roquette Freres SA, Sigachi Industries Private Limited, Spectrum Chemical Mfg. Corp., SPI Pharma Inc., The Dow Chemical Company, The Lubrizol Corporation, and Wacker Chemie AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biopharmaceutical Excipients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Excipients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Excipients Market?
4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Excipients Market?
5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Excipients Market?
6. What is the market share of the leading vendors in the Global Biopharmaceutical Excipients Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Excipients Market?
Frequently Asked Questions about the Global Biopharmaceutical Excipients Market

What is the estimated value of the Global Biopharmaceutical Excipients Market?

The Global Biopharmaceutical Excipients Market was estimated to be valued at $1725.4 Million in 2020.

What is the growth rate of the Global Biopharmaceutical Excipients Market?

The growth rate of the Global Biopharmaceutical Excipients Market is 10.3%, with an estimated value of $3437.8 Million by 2027.

What is the forecasted size of the Global Biopharmaceutical Excipients Market?

The Global Biopharmaceutical Excipients Market is estimated to be worth $3437.8 Million by 2027.

Who are the key companies in the Global Biopharmaceutical Excipients Market?

Key companies in the Global Biopharmaceutical Excipients Market include ABITEC Corporation, Ashland Global Holdings Inc., BASF SE, Clariant AG, Colorcon, Inc., DFE Pharma GmbH & Co. KG, Evonik Industries AG, Fuji Chemical Industries Co., Ltd. and Innophos Holdings, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ABITEC Corporation
  • Clariant AG
  • DFE Pharma GmbH & Co. KG
  • IMCD N.V.
  • Meggle Group GmbH
  • Roquette Freres SA

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Demand over Better Functionality and Cutting-Edge Biopharmaceutical Drug Formulations
5.1.1.2. Rise in the Need for Large-Molecule Development
5.1.1.3. Increasing Development of Biosimilars
5.1.1.4. Increasing Demand for Hormone and Gene Therapy
5.1.1.5. Bulk Vaccine Production Worldwide
5.1.2. Restraints
5.1.2.1. High Price of Biopharmaceutical Excipients
5.1.3. Opportunities
5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
5.1.3.2. Substantial Rise in Need of Functional Excipients
5.1.3.3. Developments in Recombinant DNA Technologies
5.1.4. Challenges
5.1.4.1. Safety of Biopharmaceutical Drugs and Excipients Used
5.1.4.2. Need for Large Clinical Trials in Patients
5.2. Cumulative Impact of COVID-19
6. Biopharmaceutical Excipients Market, by Product
6.1. Introduction
6.2. Carbohydrates
6.2.1. Dextrose
6.2.2. Starch
6.2.3. Sucrose
6.3. Polyols
6.3.1. Mannitol
6.3.2. Sorbitol
6.4. Solubilizers & Surfactants/Emulsifiers
6.4.1. Esters
6.4.2. Triglycerides
6.5. Specialty Excipients
7. Biopharmaceutical Excipients Market, by Function
7.1. Introduction
7.2. Binders
7.3. Coatings
7.4. Disintegrants
7.5. Lubricants & glidants
7.6. Pharmaceutical Fillers
7.7. Preservatives
8. Biopharmaceutical Excipients Market, by Application
8.1. Introduction
8.2. Advanced Delivery System
8.3. Oral
8.4. Parenteral
8.5. Topical
9. Americas Biopharmaceutical Excipients Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopharmaceutical Excipients Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Biopharmaceutical Excipients Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. ABITEC Corporation
13.2. Ashland Global Holdings Inc.
13.3. BASF SE
13.4. Clariant AG
13.5. Colorcon, Inc.
13.6. DFE Pharma GmbH & Co. KG
13.7. Evonik Industries AG
13.8. Fuji Chemical Industries Co., Ltd.
13.9. IMCD N.V.
13.10. Innophos Holdings, Inc.
13.11. J. Rettenmaier & Söhne GmbH + Co KG
13.12. Meggle Group GmbH
13.13. Merck KGaA
13.14. Pharmonix Biologicals Pvt. Ltd.
13.15. Roquette Freres SA
13.16. Sigachi Industries Private Limited
13.17. Spectrum Chemical Mfg. Corp.
13.18. SPI Pharma Inc.
13.19. The Dow Chemical Company
13.20. The Lubrizol Corporation
13.21. Wacker Chemie AG
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: DYNAMICS
FIGURE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2027 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, 2018-2027 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2027 (USD MILLION)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, 2018-2027 (USD MILLION)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2027 (USD MILLION)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2020 VS 2027 (%)
FIGURE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2020 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2027
FIGURE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2027
FIGURE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
FIGURE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, 2018-2027 (USD MILLION)
FIGURE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 53. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 46. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 51. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY STATE, 2018-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 56. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 67. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 71. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 76. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 77. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 81. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 82. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2027 (USD MILLION)
TABLE 86. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 87. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY STATE, 2018-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2018-2027 (USD MILLION)
TABLE 92. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 93. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 97. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 98. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 102. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 103. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 107. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 108. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 111. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 113. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 114. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 116. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 119. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 122. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 123. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 126. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 131. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 134. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 135. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 138. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: SCORES
TABLE 142. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BUSINESS STRATEGY
TABLE 143. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT SATISFACTION
TABLE 144. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: RANKING
TABLE 145. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 146. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: MERGER & ACQUISITION
TABLE 147. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 148. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 149. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: INVESTMENT & FUNDING
TABLE 150. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 151. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • ABITEC Corporation
  • Ashland Global Holdings Inc.
  • BASF SE
  • Clariant AG
  • Colorcon, Inc.
  • DFE Pharma GmbH & Co. KG
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD N.V.
  • Innophos Holdings, Inc.
  • J. Rettenmaier & Söhne GmbH + Co KG
  • Meggle Group GmbH
  • Merck KGaA
  • Pharmonix Biologicals Pvt. Ltd.
  • Roquette Freres SA
  • Sigachi Industries Private Limited
  • Spectrum Chemical Mfg. Corp.
  • SPI Pharma Inc.
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Wacker Chemie AG
Note: Product cover images may vary from those shown

Loading
LOADING...